Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia
Open Access
- 26 May 2020
- journal article
- editorial
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (10), 2136-2138
- https://doi.org/10.1182/bloodadvances.202000165d
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- American Society of Hematology 2019 guidelines for immune thrombocytopeniaBlood Advances, 2019
- Updated international consensus report on the investigation and management of primary immune thrombocytopeniaBlood Advances, 2019
- Diagnostik und Therapie der ImmunthrombozytopenieDeutsche Medizinische Wochenschrift (1946), 2018
- Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohortAmerican Journal of Hematology, 2017
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in FranceBlood, 2014
- Pharmacoepidemiology of Immune Thrombocytopenia: Protocols of FAITH and CARMEN StudiesTherapies, 2014
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopeniaEuropean Journal of Haematology, 2012
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopeniaBlood, 2011
- International consensus report on the investigation and management of primary immune thrombocytopeniaBlood, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009